subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307

subject_name: Green tea leaf

object_name: esophageal cancer

tested_intervention: unsure


subject: DRUGBANK:DB14307

object_name: Childhood Esophageal Carcinoma


subject: DRUGBANK:DB14307

object_name: neoplasm of esophagus


subject: DRUGBANK:DB14307

object_name: Stomach cancer


subject: DRUGBANK:DB14307

object_name: gastric cancer


subject: UNII:Q2U4R164OG

object_name: type 2 diabetes mellitus

tested_intervention: yes


subject: UMLS:C4744354

subject_name: Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)

object_name: digestive system cancer


subject: UMLS:C4744354

object_name: Plexosarcoma


subject: UMLS:C4744354


subject: UMLS:C4744354


subject: UMLS:C4744354

object_name: colorectal cancer


subject: UMLS:C4744354

object_name: colorectal carcinoma


subject: UMLS:C4744354

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4744354

object_name: pancreatic neoplasm


subject: UMLS:C4744354

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4744354

object_name: malignant pancreatic neoplasm


subject: UMLS:C4744354

object_name: neuroendocrine neoplasm


subject: UMLS:C4744354

object_name: cancer of unknown primary site


subject: UMLS:C4744354

object_name: esophageal squamous cell carcinoma


subject: UMLS:C4744354

object_name: biliary tract neoplasm


subject: UMLS:C5238988

subject_name: IDH1 inhibitor


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5238988


subject: UMLS:C5552623

subject_name: Isocitrate Dehydrogenase 1 Inhibitor [EPC]


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C5552623


subject: UMLS:C4759996

subject_name: Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C1882413

subject_name: Poly(ADP-ribose) Polymerase Inhibitors


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C1882413


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C4019076


subject: UMLS:C3838813

subject_name: BRAF inhibitor (product)


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: DRUGBANK:DB18059

object_name: rheumatoid arthritis


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: metastatic squamous cell carcinoma


subject: UMLS:C1948073


subject: CHEBI:4445

subject_name: Desflurane

object_name: Funnel Chest


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:61080

object_name: recurrent gastric cancer


subject: CHEBI:61080

object_name: esophageal adenocarcinoma


subject: CHEBI:61080

object_name: gastric adenocarcinoma


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: fallopian tube carcinoma


subject: UNII:6QVL057INT

object_name: fallopian tube cancer


subject: UNII:6QVL057INT

object_name: primary peritoneal carcinoma


subject: UNII:6QVL057INT

object_name: Primary Peritoneal Cancer


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: ovarian cancer


subject: CHEBI:73629

object_name: ovarian neoplasm


subject: CHEBI:73629

object_name: ovarian carcinoma


subject: CHEBI:73629


subject: CHEBI:73629


subject: CHEBI:73629

object_name: endometrial cancer


subject: CHEBI:73629

object_name: uterine corpus cancer


subject: CHEBI:73629

object_name: endometrial carcinoma


subject: CHEBI:73629


subject: CHEBI:73629


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: PR:000001881


subject: UMLS:C5446934

subject_name: Anti-MUC16/CD28 Bispecific Antibody REGN5668


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UMLS:C5446934


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: CHEMBL.COMPOUND:CHEMBL4594595

subject_name: UBAMATAMAB


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: UMLS:C4727043

subject_name: Ubamatamab


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: CHEBI:91464

object_name: Hepatic impairment


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Females


subject: CHEBI:50733

object_name: Males


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Prediabetes


subject: DRUGBANK:DB10640

object_name: Sedentary lifestyle


subject: DRUGBANK:DB10640


subject: DRUGBANK:DB10640


subject: UNII:R6D2UI4FLS

subject_name: Enclomiphene

object_name: Acquired Hypogonadotropic Hypogonadism


subject: UNII:R6D2UI4FLS

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:R6D2UI4FLS

object_name: obesity


subject: UNII:R6D2UI4FLS

object_name: Obesity, CTCAE


subject: UMLS:C4708725

subject_name: Alteplase 20 mg powder for solution for injection vial

object_name: pulmonary embolism


subject: UMLS:C2826163

subject_name: MUC1 Peptide-Poly-ICLC Vaccine

object_name: lung carcinoma


subject: UMLS:C1831942

object_name: benign prostatic hyperplasia


subject: UMLS:C3146272

subject_name: MART-1 Antigen (vaccine component)

object_name: skin neoplasm


subject: UMLS:C3146272

object_name: skin cancer


subject: UMLS:C1522481

subject_name: MART-1 Antigen


subject: UMLS:C1522481


subject: PR:000010436

subject_name: melanoma antigen recognized by T-cells 1


subject: PR:000010436


subject: UMLS:C0030956

subject_name: Peptides


subject: UMLS:C0030956


subject: PR:000018264

subject_name: proteolytic cleavage product


subject: PR:000018264


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG

object_name: melanoma


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C0281722

subject_name: gp100 Antigen


subject: UMLS:C0281722


subject: UMLS:C5854411

subject_name: Chk1 Inhibitor PEP07

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5854411

object_name: acute myeloid leukemia


subject: UMLS:C5854411

object_name: mantle cell lymphoma


subject: CHEBI:51098

subject_name: Motesanib

object_name: Myelofibrosis due to another disorder


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Gallstone pancreatitis


subject: CHEBI:7986

object_name: alcoholic pancreatitis


subject: UMLS:C5774009

object_name: kidney failure


subject: UMLS:C3896734

object_name: papillary renal cell carcinoma


subject: UMLS:C1831747

subject_name: Fenretinide Lipid Matrix

object_name: Childhood Neuroblastoma


subject: UMLS:C1831747

object_name: neuroblastoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Postoperative Hemorrhage


subject: CHEBI:73604

object_name: Tranexamic acid adverse reaction


subject: CHEBI:73604

object_name: fibrinolysis; hemorrhage


subject: CHEBI:73604

object_name: blood coagulation disease


subject: CHEBI:73604

object_name: hemorrhagic disease


subject: CHEBI:73604

object_name: Adverse drug response


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: B-cell non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: B-cell neoplasm


subject: UMLS:C4053580

subject_name: Anti-CD20-engineered Toxin Body MT-3724


subject: UMLS:C4053580


subject: CHEBI:61397

subject_name: Neratinib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:234112

subject_name: Cenobamate

object_name: Hepatic impairment


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: has urinary catheters at home (history)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:60799

subject_name: Esketamine


subject: CHEBI:48991

object_name: circadian rhythm sleep disorder


subject: PUBCHEM.COMPOUND:11147906

subject_name: methylxanthine


subject: CHEBI:25348


subject: UMLS:C3536939

subject_name: Methylxanthine [EPC]


subject: CHEBI:31547

subject_name: Eplerenone

object_name: proteinuria


subject: CHEBI:31547

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:31547

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:31547

object_name: Proteinuria, CTCAE 5.0


subject: PUBCHEM.COMPOUND:73417116

subject_name: TRANYLCYPROMINE

object_name: leukemia


subject: PUBCHEM.COMPOUND:73417116

object_name: childhood leukemia


subject: CHEBI:182949

subject_name: Tranylcypromine


subject: CHEBI:182949


subject: UMLS:C5446554

object_name: superficial urinary bladder carcinoma


subject: CHEBI:7773

subject_name: Ondansetron

object_name: neuralgia


subject: CHEBI:7773

object_name: Neuropathic pain


subject: CHEBI:177609

subject_name: Tariquidar


subject: CHEBI:177609


subject: UMLS:C2958908

subject_name: Injection, denosumab, 1 mg administered

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C2958908

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C2958908

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C2958908

object_name: sarcopenia


subject: UMLS:C5203422

subject_name: Denosumab Liquid Injection


subject: UMLS:C5203422


subject: UMLS:C5203422


subject: UMLS:C5203422


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:91973920

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:91973920

object_name: breast cancer


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: MESH:D056604


subject: MESH:D056604


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: DRUGBANK:DB16606


subject: DRUGBANK:DB16606


subject: UMLS:C5554945

subject_name: Ribocytokine IL-2 BNT151

object_name: Childhood Solid Neoplasm


subject: UMLS:C5554945

object_name: Adult Solid Neoplasm


subject: UMLS:C5554945

object_name: Solid Neoplasm


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: lymphedema


subject: PUBCHEM.COMPOUND:91820602

object_name: Lymphedema, CTCAE


subject: PUBCHEM.COMPOUND:91820602

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:91820602

object_name: cancer


subject: PUBCHEM.COMPOUND:91820602

object_name: childhood malignant neoplasm


subject: PUBCHEM.COMPOUND:91820602

object_name: Malignant obstetric neoplasm


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: CHEBI:6843

subject_name: Methoxyflurane

object_name: pain measurement


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: mesenchymal cell neoplasm


subject: UNII:Y68179SY2L


subject: DRUGBANK:DB17772

subject_name: Remune

object_name: Weight loss


subject: DRUGBANK:DB17772

object_name: Weight Loss, CTCAE


subject: DRUGBANK:DB17772

object_name: Malignant cachexia


subject: DRUGBANK:DB17772

object_name: lung cancer


subject: DRUGBANK:DB17772

object_name: lung neoplasm


subject: DRUGBANK:DB17772

object_name: lung carcinoma


subject: DRUGBANK:DB17772

object_name: digestive system cancer


subject: CHEBI:167309

subject_name: Methadone

object_name: Nausea and vomiting


subject: CHEBI:167309

object_name: sleep disorder


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: non-Hodgkin lymphoma


subject: CHEBI:17154

object_name: Hodgkin Disease


subject: CHEBI:7565

subject_name: Nifedipine

object_name: levator syndrome


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Hip arthropathy


subject: UMLS:C0445115

object_name: Coxitis


subject: UMLS:C0445115

object_name: osteoarthritis, hip


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: tuberculosis


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: Acute Ischemic Stroke


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: atrial fibrillation


subject: MESH:D006495

object_name: Atrial Fibrillation by ECG Finding


subject: MESH:D006495

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:6413

subject_name: Letrozole

object_name: Signal Transduction Pathway Deregulation


subject: CHEBI:6413

object_name: Treatment related secondary malignancy


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Recurrent ovarian cancer


subject: CHEBI:144094


subject: CHEBI:144094


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:94366


subject: CHEBI:50169

subject_name: Brexanolone

object_name: Tinnitus


subject: CHEBI:50169

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:50169

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C4045635

object_name: Heartburn


subject: UMLS:C4045635

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C5908033

subject_name: Anti-PD-L1/VEGF/TGF-beta Trispecific Antibody DR30206

object_name: Childhood Solid Neoplasm


subject: UMLS:C5908033

object_name: Adult Solid Neoplasm


subject: UMLS:C5908033

object_name: Solid Neoplasm


subject: UMLS:C0287816

object_name: Lewy Bodies


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: ototoxicity


subject: CHEBI:28939

object_name: Ototoxic hearing loss, bilateral


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives

object_name: Uses contraception (finding)


subject: UMLS:C0009906

object_name: HIV infection


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: liver cancer


subject: DRUGBANK:DB17107

object_name: liver neoplasm


subject: DRUGBANK:DB17107

object_name: Adult Liver Carcinoma


subject: DRUGBANK:DB17107

object_name: liver carcinoma


subject: GTOPDB:8268

subject_name: veltuzumab

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:8268

object_name: B-cell neoplasm


subject: GTOPDB:8268

object_name: prolymphocytic leukemia


subject: GTOPDB:8268

object_name: Lymphoma, Low-Grade


subject: GTOPDB:8268

object_name: Lymphoma, Mixed-Cell


subject: GTOPDB:8268

object_name: Lymphoma, Intermediate-Grade


subject: GTOPDB:8268

object_name: chronic leukemia


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: pediatric osteosarcoma


subject: GTOPDB:13085

object_name: Osteosarcoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:3757

subject_name: Clonidine

object_name: Postoperative Nausea


subject: CHEBI:3757

object_name: Vomiting, Postoperative


subject: CHEBI:3757

object_name: opioid use


subject: CHEBI:15727

subject_name: Carnosine

object_name: peripheral nervous system disorder


subject: CHEBI:15727

object_name: neuropathy


subject: CHEBI:15727

object_name: cancer


subject: CHEBI:15727

object_name: neoplasm


subject: UMLS:C0007267

subject_name: carnosine


subject: UMLS:C0007267


subject: UMLS:C0007267


subject: UMLS:C0007267


subject: CHEBI:44915

subject_name: Propofol

object_name: Chronic constipation


subject: UNII:VJ98TJ922K

object_name: heart failure


subject: UNII:VJ98TJ922K

object_name: congestive heart failure


subject: UMLS:C1176012


subject: UMLS:C1176012


subject: CHEBI:50659

subject_name: Dronedarone

object_name: Recurrent atrial fibrillation


subject: UMLS:C3826869

subject_name: SOM230 LAR

object_name: Gigantism


subject: UNII:5WD7KK1IIQ


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: DRUGBANK:DB17362

subject_name: Obecabtagene autoleucel

object_name: lupus nephritis


subject: UMLS:C5854615

subject_name: PD-L1 Inhibitor INCB099280

object_name: melanoma


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Cocaine withdrawal


subject: UMLS:C1250042

object_name: cocaine abuse


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Hypodiploid B Acute Lymphoblastic Leukemia


subject: CHEBI:4026

object_name: Precursor B-lymphoblastic lymphoma stage I


subject: CHEBI:4026

object_name: Precursor B-lymphoblastic lymphoma stage II


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: complete trisomy 21


subject: CHEBI:91872

object_name: Down syndrome


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:15640


subject: CHEBI:15640

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640

object_name: Philadelphia Chromosome Positive


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Lung squamous cell carcinoma recurrent


subject: GTOPDB:8313

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: GTOPDB:8313

object_name: FANCM Gene Mutation


subject: GTOPDB:8313

object_name: FANCA Gene Mutation


subject: GTOPDB:8313

object_name: FANCF Gene Mutation


subject: GTOPDB:8313

object_name: FANCC Gene Mutation


subject: GTOPDB:8313

object_name: FANCD2 Gene Mutation


subject: GTOPDB:8313

object_name: BRIP1 Gene Mutation


subject: GTOPDB:8313

object_name: BARD 1 gene mutation


subject: GTOPDB:8313

object_name: ATRX Gene Mutation


subject: GTOPDB:8313

object_name: RAD54L Gene Mutation


subject: GTOPDB:8313

object_name: RAD51B Gene Mutation


subject: GTOPDB:8313

object_name: Checkpoint kinase 2 gene mutation


subject: GTOPDB:8313

object_name: CHEK1 Gene Mutation


subject: GTOPDB:8313

object_name: RAD51 Gene Mutation


subject: GTOPDB:8313

object_name: RPA1 Gene Mutation


subject: GTOPDB:8313

object_name: NBN Gene Mutation


subject: GTOPDB:8313

object_name: ATR Gene Mutation


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Friedreich ataxia


subject: UMLS:C2826382

object_name: glioblastoma


subject: UMLS:C2826382

object_name: Brain Stem Glioblastoma


subject: UMLS:C2826382

object_name: glioma susceptibility 1


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: carcinoma of biliary tract


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Pleural mesothelioma malignant advanced


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Aggressive Variant Prostate Carcinoma


subject: CHEBI:63584

object_name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: metastatic prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298001


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: Metastatic Prostate Neuroendocrine Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: Secondary malignant neoplasm of brain and cerebral meninges


subject: CHEBI:49603

subject_name: Lapatinib

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:49603

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:49603

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49603

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:49603

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:49603

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:49603

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49603

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:49603

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49603

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49603

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49603

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49603

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49603

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49603

object_name: tongue cancer


subject: CHEBI:49603

object_name: tongue carcinoma


subject: CHEBI:49603

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:49603

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:49603

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49603

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:49603

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:49603

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:49603

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:49603

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49603

object_name: stage IVB salivary gland cancer


subject: CHEBI:49603

object_name: stage IVC salivary gland cancer


subject: CHEBI:49603

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49603

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49603

object_name: stage IVA salivary gland cancer


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Gastrointestinal motility disorder


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UMLS:C0723595

subject_name: Tace


subject: CHEBI:229225

subject_name: Bexagliflozin

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4520835

subject_name: Factor viii (antihemophilic factor, human) per i.u.

object_name: hemophilia A


subject: UMLS:C4718976

subject_name: Beroctocog alfa


subject: CHEBI:50156

subject_name: Canrenoic acid

object_name: Acute respiratory distress syndrome due to COVID-19


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: liver cancer


subject: CHEBI:41879

object_name: Adult Liver Carcinoma


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: acute kidney failure


subject: UMLS:C0532508


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: familial pityriasis rubra pilaris


subject: CHEBI:150712

object_name: pityriasis rubra pilaris


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: MESH:D011868

subject_name: Radioisotopes

object_name: heart failure


subject: MESH:D011868

object_name: Heart Failure, CTCAE


subject: MESH:D011868

object_name: coronary artery disorder


subject: MESH:D011868

object_name: coronary atherosclerosis


subject: CHEBI:67357

subject_name: Dolastatin 10

object_name: pancreatic neoplasm


subject: CHEBI:67357

object_name: exocrine pancreatic carcinoma


subject: CHEBI:67357

object_name: malignant pancreatic neoplasm


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UNII:3ZO554A4Q8

subject_name: Voxelotor

object_name: acute respiratory distress syndrome


subject: UNII:3ZO554A4Q8

object_name: acute lung injury


subject: UNII:3ZO554A4Q8

object_name: End stage lung disease


subject: UMLS:C0939844

subject_name: red clover preparation

object_name: Hot flashes


subject: UMLS:C0939844

object_name: Menopause present (finding)


subject: UMLS:C0939844

object_name: Menopause


subject: UMLS:C0939844

object_name: inherited lipid metabolism disorder


subject: UMLS:C0939844

object_name: Dyslipidemia


subject: UMLS:C2347906

subject_name: Anpocogin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Fractured shoulder


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Fractured rib


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:166158894

object_name: Acute Pain


subject: UMLS:C0440447

subject_name: Animal protein

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0440447

object_name: obesity


subject: UMLS:C0440447

object_name: Obesity, CTCAE


subject: UMLS:C0440447

object_name: type 2 diabetes mellitus


subject: UMLS:C0440447

object_name: Insulin resistance


subject: UMLS:C0042439

subject_name: Plant Proteins, Dietary


subject: UMLS:C0042439


subject: UMLS:C0042439


subject: UMLS:C0042439


subject: UMLS:C0042439


subject: CHEBI:9908

subject_name: Ursolic acid


subject: CHEBI:9908


subject: CHEBI:9908

object_name: Muscle Atrophy


subject: CHEBI:9908

object_name: spinal cord injury


subject: CHEBI:9908

object_name: quadriplegia


subject: CHEBI:9908

object_name: paraplegia


subject: CHEBI:62880

subject_name: Veliparib

object_name: Small cell lung cancer recurrent


subject: CHEBI:51041

subject_name: Acamprosate

object_name: autism spectrum disorder


subject: CHEBI:7465

subject_name: Naltrexone

object_name: interstitial cystitis


subject: CHEBI:7465

object_name: Painful Bladder Syndrome


subject: CHEBI:28918

subject_name: Epinephrine


subject: UMLS:C2604818

object_name: Solid Neoplasm


subject: CHEBI:63608

subject_name: Maraviroc

object_name: arteriosclerosis disorder


subject: CHEBI:63608

object_name: atherosclerosis


subject: CHEBI:63608

object_name: Heart Disease Risk Factors


subject: CHEBI:63608

object_name: HIV infection with other conditions


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Acute rejection of renal transplant


subject: UMLS:C0085297

object_name: bacteriemia


subject: UMLS:C0085297

object_name: Bacteremia, CTCAE


subject: UMLS:C0085297

object_name: Viremia


subject: UMLS:C0085297

object_name: Viremia, CTCAE


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: Moderate chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: anaplastic large cell lymphoma


subject: CHEBI:7772

subject_name: omeprazole

object_name: GERD in infants


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C4305685

subject_name: ATG-Fresenius S

object_name: Renal transplant rejection


subject: PUBCHEM.COMPOUND:73352623

subject_name: Pbmc

object_name: female infertility


subject: MESH:C561371

object_name: psoriasis vulgaris


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: mesenchymal chondrosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: pediatric mesenchymal chondrosarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:42941

object_name: colon cancer liver metastasis


subject: CHEBI:42941

object_name: Marinesco-Sjogren syndrome


subject: CHEBI:42941

object_name: Microsatellite Stable


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: common variable immunodeficiency


subject: UNII:5BKJ4Z6RBU

subject_name: ZOTIZALKIB

object_name: non-small cell lung carcinoma


subject: UNII:5BKJ4Z6RBU

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:5BKJ4Z6RBU


subject: UNII:5BKJ4Z6RBU

object_name: ALK gene mutation


subject: MESH:C000722610


subject: MESH:C000722610


subject: MESH:C000722610

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C000722610


subject: CHEBI:6121

subject_name: Ketamine

object_name: status asthmaticus


subject: CHEBI:6121

object_name: Acute severe refractory exacerbation of asthma


subject: UMLS:C5853505

object_name: congenital myasthenic syndrome


subject: UMLS:C2609633

subject_name: Divalproex Sodium ER

object_name: Drug Interactions


subject: UMLS:C2609633

object_name: Adverse drug interaction


subject: CHEBI:174348


subject: CHEBI:174348


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: CHEBI:3219

subject_name: Bupropion

object_name: Treatment related secondary malignancy


subject: UMLS:C3179143

subject_name: Nicotine Replacement Products


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Malignant melanoma of skin of breast


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C5761796

subject_name: GVAX

object_name: prostate carcinoma


subject: UMLS:C5761796

object_name: prostate cancer


subject: UMLS:C1328236

subject_name: BRENTUXIMAB

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C1328236

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: UMLS:C1328236

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: UMLS:C1328236

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: UMLS:C1328236

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: CHEBI:3011

subject_name: Benazepril

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:8774

subject_name: Ramipril


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: urticaria


subject: UNII:4F4X42SYQ6

object_name: reported urticaria (physical finding)


subject: UNII:4F4X42SYQ6

object_name: Urticaria, CTCAE


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:58097

object_name: Medication interaction potentiation


subject: CHEBI:58097

object_name: myocardial infarction


subject: CHEBI:58097

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:58097

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: PUBCHEM.COMPOUND:75038

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:75038

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:75038

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:75038

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:75038

object_name: obesity in diabetes


subject: PUBCHEM.COMPOUND:75038

object_name: Nutritional and Metabolic Diseases


subject: PUBCHEM.COMPOUND:75038

object_name: hyperglycemia


subject: PUBCHEM.COMPOUND:75038

object_name: Hyperglycemia, CTCAE


subject: PUBCHEM.COMPOUND:75038

object_name: Glucose in blood specimen above reference range


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: TRAUMA/INJURY PROBLEM


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: bile duct neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: PUBCHEM.COMPOUND:2269

object_name: coinfection


subject: PUBCHEM.COMPOUND:2269

object_name: Adverse Event Associated with Death


subject: PUBCHEM.COMPOUND:2269

object_name: Death (finding)


subject: PUBCHEM.COMPOUND:2269

object_name: Death


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:39112

subject_name: Bosutinib

object_name: autosomal dominant polycystic kidney disease


subject: GTOPDB:12347

subject_name: penpulimab

object_name: rectal carcinoma


subject: GTOPDB:12347

object_name: rectal cancer


subject: GTOPDB:12347

object_name: Childhood Rectal Carcinoma


subject: GTOPDB:12347

object_name: Locally Advanced Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: CHEBI:36796

subject_name: duloxetine

object_name: mixed anxiety and depressive disorder


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C3486820

subject_name: sesame extract

object_name: sleep disorder


subject: CHEBI:38940

subject_name: Sunitinib

object_name: plexiform neurofibroma


subject: CHEBI:4024

subject_name: Cyclopentolate

object_name: cycloplegia


subject: CHEBI:9757

subject_name: Tropicamide


subject: CHEBI:9123

subject_name: Sertraline

object_name: unreasonable fear being in open spaces or crossing bridges


subject: CHEBI:9123

object_name: agoraphobia


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:1805

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IB Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IA Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: stage IA breast cancer


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:1805

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:2038

subject_name: Azacitidine

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:2038

object_name: Breast cancer stage II


subject: CHEBI:2038

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:2038

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:2038

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:2038

object_name: stage IA breast cancer


subject: CHEBI:2038

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:2038

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:2038

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:2038

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:2038

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Ovarian cancer stage III


subject: CHEBI:114785

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:114785

object_name: ovarian undifferentiated adenocarcinoma


subject: CHEBI:114785

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:114785

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:114785

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:114785

object_name: ovarian Brenner tumor


subject: CHEBI:114785

object_name: Brenner tumor


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: salivary gland cancer


subject: CHEBI:31898

object_name: Neck Carcinoma


subject: CHEBI:31898

object_name: head and neck neoplasm


subject: CHEBI:31898

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: bipolar I disorder


subject: CHEBI:28939

object_name: bipolar II disorder


subject: CHEBI:31709

subject_name: Iohexol

object_name: Drug Interactions


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: HIV infection


subject: CHEBI:6067

object_name: dysplasia of cervix


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: sinonasal undifferentiated carcinoma


subject: PUBCHEM.COMPOUND:44278770

subject_name: SANDOSTATIN

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:44278770

object_name: prostate cancer


subject: CHEBI:28864

subject_name: Tobramycin

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UniProtKB:Q8WWQ3

subject_name: MUC5AC protein, human


subject: PR:000031343


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: interstitial lung disease 2


subject: UMLS:C0963149

subject_name: Definity

object_name: thyroid tumor


subject: UMLS:C0963149

object_name: thyroid gland carcinoma


subject: UMLS:C0963149

object_name: thyroid cancer


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: CHEBI:31980


subject: CHEBI:16899

subject_name: Mannitol

object_name: allergic asthma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: transient ischemic attack


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: Ischemic stroke


subject: CHEBI:38562


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Dyspnea


subject: CHEBI:26710

object_name: Dyspnea, CTCAE


subject: CHEBI:26710

object_name: cardiovascular surgery result: dyspnea


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Progesterone receptor positive tumor


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Estrogen receptor positive tumor


subject: UNII:V5Y646AW8S

object_name: cerebral palsy


subject: CHEBI:2618

subject_name: Amantadine


subject: UNII:Y35B3VA60V

subject_name: Cinepazide Maleate


subject: UMLS:C0055741

subject_name: cinepazide maleate


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Tachycardia by ECG Finding


subject: CHEBI:33569

object_name: Tachycardia


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Sepsis


subject: CHEBI:8093

object_name: Sepsis, CTCAE


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: hypertriglyceridemia


subject: CHEBI:49040

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:23359

subject_name: colchicine

object_name: Dependence


subject: UNII:Z7HVY03PHP

subject_name: Mirikizumab

object_name: Chronic small plaque psoriasis


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C1710686

object_name: Brain Stem Glioblastoma


subject: UMLS:C1710686

object_name: glioma susceptibility 1


subject: UMLS:C3153967

subject_name: Refresh Optive

object_name: dry eye syndrome


subject: RXCUI:25655

subject_name: Gaviscon

object_name: Heartburn


subject: RXCUI:25655

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: type 1 diabetes mellitus


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:15940

subject_name: Niacin

object_name: Perceptual disturbance


subject: CHEBI:15940

object_name: Psychedelic Experiences


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:139072


subject: CHEBI:8614

subject_name: Psilocybin


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: UMLS:C0733521

subject_name: Ara-C


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4026

object_name: acquired aplastic anemia


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Systemic embolism


subject: CHEBI:85974

object_name: Rheumatic mitral stenosis


subject: CHEBI:85974

object_name: Mitral stenosis


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: UMLS:C4733679

subject_name: ADC BA3011

object_name: myxofibrosarcoma


subject: UMLS:C4733679

object_name: undifferentiated pleomorphic sarcoma


subject: UMLS:C4733679

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:53760

object_name: Fatigue


subject: CHEBI:53760

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:7772

subject_name: omeprazole

object_name: ulcerative colitis


subject: CHEBI:7772

object_name: inflammatory bowel disease 1


subject: UMLS:C5417835

subject_name: HIF2a RNAi ARO-HIF2

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5417835

object_name: clear cell renal carcinoma


subject: CHEBI:84500

subject_name: varenicline

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:84500

object_name: obesity


subject: CHEBI:84500

object_name: Obesity, CTCAE


subject: UMLS:C5854444

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:142708

object_name: primary biliary cholangitis


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: Presenile dementia


subject: CHEBI:50949

object_name: dementia


subject: CHEBI:50949

object_name: mild neurocognitive disorder


subject: CHEBI:50949

object_name: mild cognitive impairment


subject: CHEBI:50949

object_name: Alzheimer disease type 1


subject: CHEBI:50949

object_name: Alzheimer disease


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C0360105


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: UMLS:C2911696


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Low back pain


subject: UMLS:C5959328

subject_name: AMT 707

object_name: ovarian cancer


subject: UMLS:C5959328

object_name: ovarian neoplasm


subject: UMLS:C5959328

object_name: ovarian carcinoma


subject: UMLS:C5959328

object_name: Childhood Solid Neoplasm


subject: UMLS:C5959328

object_name: Adult Solid Neoplasm


subject: UMLS:C5959328

object_name: Solid Neoplasm


subject: UMLS:C5964766

object_name: biliary tract cancer


subject: UMLS:C5964766

object_name: liver carcinoma


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Adult Myelodysplastic Syndrome


subject: UNII:AQK7UBA1LS

object_name: childhood myelodysplastic syndrome


subject: UNII:AQK7UBA1LS

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: CHEBI:91951

object_name: Metastatic HER2-Positive Breast Carcinoma


subject: CHEBI:91951

object_name: Locally Advanced HER2-Positive Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905

object_name: invasive breast carcinoma


subject: CHEBI:230905

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:230905


subject: CHEBI:230905

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:230905

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: Metastatic HER2-Positive Breast Carcinoma


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: chronic kidney disease


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Embolism, Tumor


subject: CHEBI:49960

object_name: Advanced cancer


subject: CHEBI:49960

object_name: refractory malignant neoplasm


subject: CHEBI:49960

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:36080

subject_name: protein

object_name: Overweight


subject: CHEBI:36080

object_name: Android obesity


subject: CHEBI:36080

object_name: Abdominal obesity


subject: UMLS:C0033684

subject_name: Proteins


subject: UMLS:C0033684


subject: UMLS:C0033684


subject: PR:000000001


subject: PR:000000001


subject: PR:000000001


subject: UMLS:C2984025

subject_name: Ferinject

object_name: celiac disease


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: lupus nephritis


subject: CHEBI:27812

object_name: lupus erythematosus


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: lung cancer


subject: CHEBI:47808

object_name: lung neoplasm


subject: CHEBI:47808

object_name: lung carcinoma


subject: CHEBI:27812

object_name: diabetes mellitus


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Pruritus, CTCAE


subject: UMLS:C3658854


subject: CHEMBL.COMPOUND:CHEMBL5315126

subject_name: FOLLITROPIN BETA

object_name: Encounter due to In vitro fertilization


subject: UMLS:C0060787

subject_name: follitropin beta


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: thyroid tumor


subject: CHEBI:3311

object_name: thyroid cancer


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:57694

object_name: Menopause present (finding)


subject: CHEBI:57694

object_name: Menopause


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Metastatic malignant neoplasm to peritoneum


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8


subject: MESH:C520255

object_name: intrahepatic cholangiocarcinoma


subject: MESH:C520255

object_name: Distal Cholangiocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:6605

subject_name: lysergide

object_name: Depressed mood


subject: CHEBI:6605

object_name: Cancer patients and suicide and depression


subject: CHEBI:6605

object_name: Depressed - symptom


subject: CHEBI:6605

object_name: Depression, CTCAE


subject: CHEBI:6605

object_name: endogenous depression


subject: CHEBI:6605

object_name: major depressive disorder


subject: PR:000006595

subject_name: deoxyribonuclease gamma


subject: PR:000006595


subject: PR:000006595


subject: PR:000006595


subject: PR:000006595


subject: PR:000006595


subject: CHEBI:8081

subject_name: Phentolamine

object_name: congestive heart failure


subject: UMLS:C0445115

subject_name: Normal saline

object_name: bariatric surgery candidate


subject: UMLS:C0445115

object_name: Overweight and obesity


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C4733690

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: respiratory system disorder


subject: CHEBI:85164


subject: UMLS:C4087029

object_name: Refractory Neuroblastoma


subject: UMLS:C4087029

object_name: malignant soft tissue neoplasm


subject: UNII:9K8GNJ2874

subject_name: Naxitamab


subject: UMLS:C4054758

subject_name: naxitamab


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Allergy


subject: PUBCHEM.COMPOUND:74030550

object_name: hypersensitivity reaction disease


subject: PUBCHEM.COMPOUND:74030550

object_name: Emotional hypersensitivity


subject: PUBCHEM.COMPOUND:74030550

object_name: anaphylaxis


subject: PUBCHEM.COMPOUND:74030550

object_name: Anaphylaxis;non medication


subject: PUBCHEM.COMPOUND:74030550

object_name: Anaphylaxis, CTCAE


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: dientamoebiasis


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:17754

subject_name: Glycerin

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL2108076

subject_name: PARAFFIN


subject: UMLS:C0497805

subject_name: PARAFFIN, PER POUND


subject: UMLS:C0302908

subject_name: Liquid substance


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: adult liposarcoma


subject: UMLS:C5853669

object_name: type 2 diabetes mellitus


subject: UMLS:C5853669

object_name: Diabetes


subject: UMLS:C5853669

object_name: diabetes mellitus


subject: UMLS:C5853669

object_name: Full thickness burn


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: adult lymphoma


subject: CHEBI:28793

object_name: lymphoma


subject: CHEBI:28793

object_name: pediatric lymphoma


subject: CHEBI:28793

object_name: leukemia


subject: CHEBI:28793

object_name: childhood leukemia


subject: CHEBI:28793

object_name: lymphoproliferative syndrome


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Ventricular Dysfunction


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:4445

subject_name: Desflurane


subject: PUBCHEM.COMPOUND:122316

object_name: Depressive Symptoms


subject: CHEBI:63620

subject_name: Rasagiline


subject: UMLS:C4507515

object_name: atypical hemolytic-uremic syndrome


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Respiratory System Finding


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: EGFR Exon 20 Insertion Mutation


subject: CHEBI:351346

subject_name: Phenethyl Isothiocyanate

object_name: outcomes general quality of life


subject: CHEBI:351346

object_name: Perceived quality of life


subject: CHEBI:351346

object_name: Good quality of life


subject: CHEBI:351346

object_name: head and neck neoplasm


subject: CHEBI:351346

object_name: nutrition related cancer


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:233364

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:233364

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:233364

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:233364

object_name: splenic marginal zone lymphoma


subject: CHEBI:233364

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:233364

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:233364

object_name: MALT lymphoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: vulvovaginal candidiasis


subject: PUBCHEM.COMPOUND:91302628

object_name: Decompensated cirrhosis of liver


subject: CHEBI:82977

subject_name: Daclatasvir


subject: CHEBI:83800

subject_name: daclatasvir hydrochloride


subject: UMLS:C4046850

subject_name: Daklinza


subject: UMLS:C1170576

subject_name: Rebetol


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Postmenopausal


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:4875

subject_name: Etanercept


subject: CHEBI:4875

object_name: osteoporosis


subject: CHEBI:4875

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:4875

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:4875

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:4875

object_name: Osteopenia


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: UMLS:C0013705

subject_name: Egg White Proteins

object_name: food allergy


subject: UMLS:C0013705

object_name: Hypersensitivity reaction caused by food


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: lung cancer


subject: CHEBI:78887

object_name: lung neoplasm


subject: CHEBI:78887

object_name: lung carcinoma


subject: UMLS:C2092230

subject_name: Betamethasone Sodium Phosphate Injection

object_name: congenital alveolar dysplasia


subject: UMLS:C2092230

object_name: newborn respiratory distress syndrome


subject: UMLS:C2092230

object_name: Neonatal Respiratory Distress Syndrome, AE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0308804

subject_name: Dexamethasone Sodium Phosphate Injection


subject: UMLS:C0308804


subject: UMLS:C0308804


subject: UNII:QX6O64GP40

subject_name: Proxalutamide

object_name: Frontal balding


subject: UNII:QX6O64GP40

object_name: benign prostatic hyperplasia


subject: UNII:QX6O64GP40

object_name: prostate carcinoma


subject: UNII:QX6O64GP40

object_name: prostate cancer


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Sepsis


subject: CHEBI:47898

object_name: Sepsis, CTCAE


subject: GTOPDB:4981

object_name: HIV infection


subject: PR:000001373


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Refractory Thyroid Gland Carcinoma


subject: CHEBI:145371

object_name: Metastatic Thyroid Gland Carcinoma


subject: CHEBI:145371

object_name: BRAF V600E Mutation Present


subject: CHEBI:145371

object_name: Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:145371

object_name: Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:145371

object_name: Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8


subject: CHEBI:145371


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: acoustic neuroma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Adenocarcinoma of lung, stage III


subject: UMLS:C1883555

subject_name: Whey Protein Isolate

object_name: Physical function


subject: UMLS:C1883555

object_name: outcomes general quality of life


subject: UMLS:C1883555

object_name: Perceived quality of life


subject: UMLS:C1883555

object_name: Good quality of life


subject: UMLS:C1883555

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1883555

object_name: metabolic syndrome X


subject: UMLS:C1883555

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1883555

object_name: obesity


subject: UMLS:C1883555

object_name: Obesity, CTCAE


subject: UMLS:C0723712

subject_name: Therapeutic brand of coal tar

object_name: Neck Carcinoma


subject: UMLS:C0723712

object_name: head and neck neoplasm


subject: UMLS:C0723712

object_name: head and neck cancer


subject: UMLS:C0723712

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C0723712

object_name: cervical adenocarcinoma


subject: UMLS:C0723712

object_name: non-small cell lung carcinoma


subject: UMLS:C0723712

object_name: transitional cell carcinoma


subject: UMLS:C0723712

object_name: colorectal adenocarcinoma


subject: UMLS:C5854562

subject_name: FRa/TRPV6 Bispecific Ligand-drug Conjugate CBP-1019

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854562

object_name: Adult Solid Neoplasm


subject: UMLS:C5854562

object_name: Solid Neoplasm


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: CHEBI:68534


subject: UMLS:C0972569

subject_name: Electrophoresis Gel

object_name: psoriasis vulgaris


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: childhood onset asthma


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: diffuse glioma, H3 G34 mutant


subject: UNII:0JSR7Z0NB6

object_name: glioblastoma


subject: UMLS:C4085970


subject: UMLS:C4085970


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: lung adenocarcinoma


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C5544272

object_name: bronchiectasis


subject: UMLS:C5544272

object_name: cystic fibrosis


subject: UNII:S66Z65E10T

subject_name: CEMDISIRAN

object_name: Myasthenia Gravis, Generalized


subject: GTOPDB:12900

subject_name: pozelimab


subject: UNII:0JJ21K6L2I

subject_name: Pozelimab


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Foot Ulcer


subject: CHEBI:144903

object_name: diabetic foot


subject: CHEBI:144903

object_name: chronic diabetic foot ulcer of right foot


subject: CHEBI:144903

object_name: Diabetic foot infection


subject: CHEBI:144903

object_name: chronic diabetic ulcer of left foot


subject: CHEBI:144903

object_name: Neuropathic ulcer of foot due to diabetes mellitus


subject: CHEBI:144903

object_name: Foot ulcer due to type 2 diabetes mellitus


subject: CHEBI:144903

object_name: Ulcer of foot due to type 1 diabetes mellitus


subject: CHEBI:144903

object_name: Complications of Diabetes Mellitus


subject: CHEBI:144903

object_name: diabetes mellitus


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Perinatal anoxic-ischemic brain injury


subject: CHEBI:7421

subject_name: NAC


subject: UNII:7SE5582Q2P

subject_name: Vosoritide

object_name: mucopolysaccharidosis type 4A


subject: UNII:7SE5582Q2P

object_name: mucopolysaccharidosis type 6


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Acute lower respiratory tract infection


subject: CHEBI:89324

object_name: bronchiolitis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Scorpion sting


subject: CHEBI:41879

object_name: scorpion envenomation


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Drug Interactions


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: Inflammatory Response


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: UMLS:C2606890

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C2606890

object_name: amyotrophic lateral sclerosis


subject: UMLS:C4721940

object_name: colon carcinoma


subject: UMLS:C4721940

object_name: colorectal cancer


subject: UMLS:C4721940

object_name: colon cancer


subject: UMLS:C4721940

object_name: lung cancer


subject: UMLS:C4721940

object_name: lung neoplasm


subject: UMLS:C4721940

object_name: lung carcinoma


subject: UMLS:C4721940

object_name: pancreatic neoplasm


subject: UMLS:C4721940

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4721940

object_name: malignant pancreatic neoplasm


subject: UMLS:C4721940

object_name: Childhood Breast Carcinoma


subject: UMLS:C4721940

object_name: breast carcinoma


subject: UMLS:C4721940

object_name: breast cancer


subject: UMLS:C4721940

object_name: colorectal carcinoma


subject: UMLS:C4721940

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:16494

subject_name: thioctic acid

object_name: ischemic cardiomyopathy


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Food Addiction


subject: CHEBI:30797

subject_name: (S)-malic acid

object_name: hypertension


subject: CHEBI:30797

object_name: Hypertension, CTCAE


subject: CHEBI:30797

object_name: Depressed mood


subject: CHEBI:30797

object_name: Cancer patients and suicide and depression


subject: CHEBI:30797

object_name: Depressed - symptom


subject: CHEBI:30797

object_name: Depression, CTCAE


subject: CHEBI:6650

subject_name: Malic acid


subject: CHEBI:6650


subject: CHEBI:6650


subject: CHEBI:6650


subject: CHEBI:6650


subject: CHEBI:6650


subject: CHEBI:16587

subject_name: ecdystene


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: arteriosclerosis disorder


subject: UNII:8K80YB5GMG

object_name: atherosclerosis


subject: UNII:8K80YB5GMG

object_name: coronary artery disorder


subject: UNII:8K80YB5GMG

object_name: coronary atherosclerosis


subject: UNII:8K80YB5GMG

object_name: coronary microvascular disorder


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UMLS:C2343505


subject: UMLS:C2343505


subject: UMLS:C2343505


subject: UMLS:C2343505


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: Muscle spasm


subject: UMLS:C0002521

object_name: Muscle Cramp, CTCAE


subject: UMLS:C0002521

object_name: outcomes general quality of life


subject: UMLS:C0002521

object_name: Perceived quality of life


subject: UMLS:C0002521

object_name: Good quality of life


subject: CHEMBL.COMPOUND:CHEMBL4298190

subject_name: OMIDUBICEL

object_name: Severe Aplastic Anemia


subject: CHEMBL.COMPOUND:CHEMBL4298190

object_name: severe aplastic anemia


subject: CHEMBL.COMPOUND:CHEMBL5095231

subject_name: TULMIMETOSTAT

object_name: non-small cell lung carcinoma


subject: UNII:OUQ4N85Z0B


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Irritable heart


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:33364

subject_name: Platinum

object_name: multiple sclerosis


subject: CHEBI:75318

subject_name: petunidin


subject: CHEBI:141395

subject_name: Pro-Thr


subject: CHEBI:176724

subject_name: Etiracetam

object_name: body dysmorphic disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:125354

subject_name: Plerixafor

object_name: pancreatic neoplasm


subject: CHEBI:125354

object_name: exocrine pancreatic carcinoma


subject: CHEBI:125354

object_name: malignant pancreatic neoplasm


subject: UMLS:C3896869

subject_name: CAIX Inhibitor DTP348

object_name: Solid Neoplasm


subject: UMLS:C3896869

object_name: head and neck neoplasm


subject: CHEBI:4445

subject_name: Desflurane

object_name: Encounter due to postsurgical aortocoronary bypass status


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:9130

subject_name: Sevoflurane


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: HCV coinfection


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: chronic hepatitis B virus infection


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Acute myocardial ischemia


subject: CHEBI:404903

subject_name: Ertapenem

object_name: gonorrhea


subject: CHEBI:5312

subject_name: gentamicin sulfate


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: UMLS:C0086466

subject_name: Injectables


subject: UMLS:C4765216

subject_name: YSPSL

object_name: Delayed Graft Function


subject: UMLS:C4765363

subject_name: rPSGL-Ig


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: primary progressive multiple sclerosis


subject: UMLS:C4329329

object_name: ovarian neoplasm


subject: CHEBI:94782

subject_name: Cediranib

object_name: pancreatic adenocarcinoma


subject: CHEBI:94782

object_name: leiomyosarcoma


subject: CHEBI:94782

object_name: Childhood Leiomyosarcoma


subject: CHEBI:94782

object_name: Adult Leiomyosarcoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: GTOPDB:12991

subject_name: prolgolimab

object_name: Hodgkin Disease


subject: GTOPDB:12991

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:12991

object_name: Childhood Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314998

subject_name: PROLGOLIMAB


subject: CHEMBL.COMPOUND:CHEMBL5314998


subject: CHEMBL.COMPOUND:CHEMBL5314998


subject: UMLS:C4724855

subject_name: BCD 100


subject: UMLS:C4724855


subject: UMLS:C4724855


subject: UMLS:C5554963

subject_name: Multi-kinase Inhbitor AIV001

object_name: skin carcinoma


subject: UMLS:C5554963

object_name: nodular basal cell carcinoma


subject: UMLS:C5554963

object_name: superficial multifocal basal cell carcinoma


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: multiple organ dysfunction syndrome


subject: UMLS:C0594372

subject_name: Avonex


subject: DRUGBANK:DB16512


subject: PR:000006600

subject_name: DNL-type zinc finger protein


subject: PR:000006600

object_name: Coronavinae infectious disease


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: grade II glioma


subject: UMLS:C3898831

object_name: grade III glioma


subject: UMLS:C3898831

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: syphilis infection


subject: CHEBI:60648

object_name: AIDS


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C0359180

subject_name: albumin solution

object_name: adrenomyeloneuropathy


subject: UMLS:C0359180

object_name: adrenoleukodystrophy


subject: UMLS:C0359180

object_name: X-linked cerebral adrenoleukodystrophy


subject: CHEBI:50172

subject_name: acitretin

object_name: HIV infection


subject: CHEBI:50174


subject: UNII:DRJ25J548U

subject_name: Capsaicin palmitate

object_name: diabetic foot


subject: UNII:DRJ25J548U

object_name: Diabetic peripheral neuropathy


subject: UNII:DRJ25J548U

object_name: Diabetic Neuralgia


subject: UMLS:C3883327

subject_name: capsaicin palmitate


subject: UMLS:C3883327


subject: UMLS:C3883327


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Fibrosis of the skin


subject: CHEBI:51450

subject_name: Bosentan


subject: UMLS:C5848530

subject_name: Astragalus membranaceus

object_name: cancer-related condition


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:93776

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:93776

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: lupus nephritis


subject: UNII:B72HH48FLU

object_name: EXCESS LMW-DNA


subject: UMLS:C4725916

subject_name: Anti-CD26 Monoclonal Antibody YS110

object_name: malignant pleural mesothelioma


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: Infection in solid organ transplant recipients


subject: PUBCHEM.COMPOUND:138594142

object_name: type 2 diabetes mellitus


subject: UNII:7N8KHW7Y6A


subject: PUBCHEM.COMPOUND:126481870

subject_name: valemetostat

object_name: lung cancer


subject: PUBCHEM.COMPOUND:126481870

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:126481870

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: non-small cell squamous lung carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:126481870

object_name: head and neck cancer


subject: UNII:60RD0234VE

subject_name: Valemetostat


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: CHEBI:71954

subject_name: Buparlisib

object_name: follicular lymphoma


subject: CHEBI:71954

object_name: diffuse large B-cell lymphoma


subject: CHEBI:71954

object_name: adult lymphoma


subject: CHEBI:71954

object_name: lymphoma


subject: CHEBI:71954

object_name: pediatric lymphoma


subject: CHEBI:71954

object_name: mantle cell lymphoma


subject: CHEBI:71013

subject_name: Perampanel

object_name: Bilateral tonic-clonic seizure


subject: UMLS:C1436435

subject_name: NTZ

object_name: multiple sclerosis


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: UMLS:C3714737

subject_name: Phytonadione Drug Class

object_name: Blood Clot


subject: UMLS:C3714737

object_name: thrombosis


subject: UMLS:C3714737

object_name: Thrombosis of blood vessel


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: prostate carcinoma


subject: CHEBI:91397

object_name: prostate cancer


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: Harmful pattern of substance use


subject: RXCUI:8375

object_name: substance abuse


subject: GTOPDB:8265

subject_name: abagovomab

object_name: fallopian tube carcinoma


subject: GTOPDB:8265

object_name: fallopian tube cancer


subject: GTOPDB:8265

object_name: peritoneum cancer


subject: CHEMBL.COMPOUND:CHEMBL1742981

subject_name: ABAGOVOMAB


subject: CHEMBL.COMPOUND:CHEMBL1742981


subject: CHEMBL.COMPOUND:CHEMBL1742981


subject: UMLS:C1832044


subject: UMLS:C1832044


subject: UMLS:C1832044


subject: UMLS:C0962969

subject_name: RAD 001

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0962969

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C0962969

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C5205492

subject_name: PD-1 Directed Probody CX-188

object_name: Adult Solid Neoplasm


subject: CHEBI:16118

subject_name: Berberine

object_name: chronic kidney disease


subject: CHEBI:16118

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4725725

subject_name: Copper Cu-64-DOTA-alendronate

object_name: Calcification


subject: UMLS:C4725725

object_name: calcinosis


subject: UMLS:C4725725

object_name: breast carcinoma


subject: UMLS:C3463871

subject_name: Allergen (brand of antipyrine/benzocaine)

object_name: anaphylaxis


subject: UMLS:C3463871

object_name: Anaphylaxis;non medication


subject: UMLS:C3463871

object_name: Anaphylaxis, CTCAE


subject: UMLS:C3274161

subject_name: Allergen (brand of diphenylpyraline)


subject: UMLS:C3274161


subject: UMLS:C3274161


subject: MESH:D000485

subject_name: Allergens


subject: MESH:D000485


subject: MESH:D000485


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Thromboembolism


subject: CHEBI:85993

object_name: immune system disorder


subject: CHEBI:85993

object_name: inflammatory disease


subject: CHEBI:85993

object_name: cardiovascular disorder


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Childhood Solid Neoplasm


subject: CHEBI:68579


subject: CHEBI:68579

object_name: Solid Neoplasm


subject: CHEBI:68579

object_name: lung cancer


subject: CHEBI:68579

object_name: lung neoplasm


subject: CHEBI:68579

object_name: lung carcinoma


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579

object_name: colon carcinoma


subject: CHEBI:68579

object_name: colorectal cancer


subject: CHEBI:68579

object_name: Childhood Breast Carcinoma


subject: CHEBI:68579


subject: CHEBI:68579

object_name: breast cancer


subject: CHEBI:68579

object_name: prostate carcinoma


subject: CHEBI:68579

object_name: prostate cancer


subject: UMLS:C1706415

subject_name: Interleukin-3 Receptor alpha Subunit

object_name: B-Cell Leukemia


subject: UMLS:C1706415

object_name: B-cell chronic lymphocytic leukemia


subject: PR:000001865

subject_name: interleukin-3 receptor class 2 alpha chain


subject: PR:000001865


subject: UMLS:C0025250

subject_name: Neprilysin


subject: UMLS:C0025250


subject: UniProtKB:Q8R4S8

subject_name: CRLF2_RAT Cytokine receptor-like factor 2 (sprot)


subject: UniProtKB:Q8R4S8


subject: PR:000005886

subject_name: cytokine receptor-like factor 2


subject: PR:000005886


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: hypertension


subject: PUBCHEM.COMPOUND:27991

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: UMLS:C0086135

subject_name: DDAVP


subject: UMLS:C0086135


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:4653


subject: UMLS:C0732282

subject_name: Aggrenox


subject: UMLS:C0732282


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:3395


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:5558

subject_name: Guanfacine


subject: CHEBI:5558


subject: PUBCHEM.COMPOUND:6420057

subject_name: METOPROLOL TARTRATE


subject: PUBCHEM.COMPOUND:6420057


subject: CHEBI:132912

subject_name: nebivolol hydrochloride


subject: CHEBI:132912


subject: CHEBI:9398

subject_name: Tamsulosin


subject: CHEBI:9398


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Plasma cell myeloma recurrent


subject: UNII:7D0YB67S97

object_name: Plasma cell myeloma refractory


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UNII:L0O9OBI87E

subject_name: Bizelesin

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:94366

subject_name: itraconazole

object_name: brain neoplasm


subject: CHEBI:94366

object_name: nephroblastoma


subject: CHEBI:94366

object_name: Wilms tumor


subject: CHEBI:94366

object_name: childhood kidney Wilms tumor


subject: CHEBI:94366

object_name: retinoblastoma


subject: CHEBI:94366

object_name: Childhood Neuroblastoma


subject: CHEBI:94366

object_name: neuroblastoma


subject: UNII:98OYR854NY

subject_name: Trabedersen

object_name: non-small cell lung carcinoma


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Oral Intraepithelial Neoplasia


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Complication of hemodialysis


subject: PUBCHEM.COMPOUND:5281767

object_name: Haemodialysis-induced symptom


subject: UNII:TUK9QB44B0

object_name: Metastatic adenoid cystic carcinoma


subject: UMLS:C5392518


subject: UMLS:C0370003

subject_name: Specimen

object_name: endometriosis


subject: UMLS:C5446641

subject_name: ESR1 Peptides/GM-CSF/Montanide ISA Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C5446641

object_name: breast carcinoma


subject: UMLS:C5446641

object_name: breast cancer


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Neuropathic pain


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: hypercalcemia


subject: UNII:6XC1PAD3KF

object_name: Hypercalcemia, CTCAE


subject: UNII:6XC1PAD3KF


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: UMLS:C0939788

subject_name: Zometa


subject: UMLS:C0939788


subject: UMLS:C0939788

object_name: cancer


subject: UMLS:C0939788


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Nutritional stunting


subject: PUBCHEM.COMPOUND:3085828

subject_name: Gadoteric acid

object_name: kidney failure


subject: PUBCHEM.COMPOUND:3085828

object_name: Renal dysfunction


subject: CHEBI:73735

subject_name: gadoterate


subject: CHEBI:73735


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate

object_name: bladder tumor


subject: UMLS:C1706792

object_name: urinary bladder carcinoma


subject: UMLS:C1706792

object_name: urinary bladder cancer


subject: UMLS:C1706792

object_name: childhood bladder carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Drug toxicity


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: neoplasm of esophagus


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: urothelial carcinoma


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145

object_name: transitional cell carcinoma


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: c.delivery; previous surgery, gynecological


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:31627

subject_name: FP 83


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron


subject: MESH:D022242

subject_name: Pneumococcal Vaccines

object_name: Lobar Pneumonia


subject: MESH:D022242

object_name: streptococcal pneumonia


subject: UMLS:C5240157

subject_name: Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


subject: UMLS:C5240157


subject: UNII:H1396W7D1H

subject_name: FAVEZELIMAB

object_name: neoplasm


subject: UMLS:C4684393

subject_name: Favezelimab


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate


subject: UMLS:C1832026

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: cannabinoid hyperemesis syndrome


subject: CHEBI:4717

subject_name: Droperidol


subject: UMLS:C5544290


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: sleep apnea


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: prostate adenocarcinoma


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: PUBCHEM.COMPOUND:3367

object_name: myelodysplastic syndrome with excess blasts-2


subject: PUBCHEM.COMPOUND:3367

object_name: myelodysplastic syndrome with excess blasts-1


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: UMLS:C4725946

subject_name: Panobinostat Nanoparticle Formulation MTX110

object_name: diffuse midline glioma


subject: CHEBI:33375

subject_name: Gadolinium

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:33375


subject: CHEBI:33375

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: MESH:C000722701

subject_name: ZR-202-CoV COVID-19 vaccine


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: trabecular adenocarcinoma


subject: UNII:MRL3739G66

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:45II35329V

subject_name: Setanaxib

object_name: Liver Stiffness


subject: UNII:45II35329V

object_name: primary biliary cholangitis


subject: CHEBI:7459

subject_name: Naloxone

object_name: Morphine adverse reaction


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:36333

object_name: obesity


subject: CHEBI:36333

object_name: Obesity, CTCAE


subject: UMLS:C3540789

subject_name: Local anesthetics for treatment of hemorrhoids and anal fissures for topical use


subject: UMLS:C3540789


subject: UMLS:C3540789


subject: UMLS:C3540789

object_name: bariatric surgery candidate


subject: UMLS:C3541403

subject_name: Local anesthetics, ophthalmologic


subject: UMLS:C3541403


subject: UMLS:C3541403


subject: UMLS:C3541403


subject: UMLS:C5666869

subject_name: BTK inhibitor TG-1701

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5666869

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: malignant pleural mesothelioma


subject: CHEBI:85164


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Brain Stem Glioblastoma


subject: CHEBI:41879

object_name: glioma susceptibility 1


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: glioblastoma


subject: UNII:DWN2WN457X


subject: UNII:DWN2WN457X


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: hepatic veno-occlusive disease


subject: CHEBI:17061

object_name: pulmonary venoocclusive disease


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: UMLS:C5848865

subject_name: Cell Therapy [APC]

object_name: Recurrent disease


subject: UMLS:C5848865

object_name: Global Relapse in Viscera


subject: UMLS:C5848865

object_name: Global Relapse in Lymph Nodes


subject: UMLS:C5848865

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UMLS:C5848865

object_name: Global Relapse


subject: UMLS:C5848865

object_name: Global Relapse in Skin


subject: UMLS:C5848865

object_name: Global Relapse in Blood


subject: UMLS:C5848865

object_name: Neck Carcinoma


subject: UMLS:C5848865

object_name: head and neck neoplasm


subject: UMLS:C5848865

object_name: head and neck cancer


subject: UMLS:C5848865

object_name: refractory malignant neoplasm


subject: UMLS:C5848865

object_name: Recurrent tumor


subject: UMLS:C5907959

subject_name: DGK-alpha Inhibitor GS-9911

object_name: Solid Neoplasm


subject: CHEBI:8028

subject_name: Perphenazine

object_name: Acute Ischemic Stroke


subject: CHEBI:8502

subject_name: Propylthiouracil


subject: CHEBI:76018

subject_name: Riociguat